You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Citation Tools

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
D'Angelo SP, Bhatia S, Brohl AS, et al
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
Journal for ImmunoTherapy of Cancer 2020;8:e000674. doi: 10.1136/jitc-2020-000674